Reviva Pharmaceuticals Hldg Inc (RVPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 02-2020 | 12-2019 | 02-2019 | 12-2018 | 02-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 618 | -847 | 574 | 268 | 260 |
| Depreciation Amortization | N/A | 1 | N/A | 0 | 0 |
| Accounts payable and accrued liabilities | N/A | 158 | N/A | N/A | N/A |
| Other Working Capital | 298 | 634 | -68 | -38 | -30 |
| Other Operating Activity | -1,343 | -165 | -727 | -363 | -360 |
| Operating Cash Flow | $-427 | $-218 | $-221 | $-133 | $-130 |
| Cash Flows From Investing Activities | |||||
| Purchase Of Investment | -567 | N/A | -64,515 | N/A | N/A |
| Other Investing Activity | 6,269 | 0 | 0 | -64,515 | -64,510 |
| Investing Cash Flow | $5,702 | $N/A | $-64,515 | $-64,515 | $-64,510 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 750 | 100 | N/A | N/A | N/A |
| Debt Repayment | N/A | N/A | -363 | N/A | N/A |
| Common Stock Issued | N/A | N/A | 65,440 | N/A | N/A |
| Common Stock Repurchased | -6,269 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 0 | 0 | -28 | 65,049 | 65,040 |
| Financing Cash Flow | $-5,519 | $100 | $65,049 | $65,049 | $65,040 |
| Beginning Cash Position | 313 | 119 | N/A | 0 | 0 |
| End Cash Position | 69 | 0 | 313 | 401 | 400 |
| Net Cash Flow | $-244 | $-118 | $313 | $401 | $400 |
| Free Cash Flow | |||||
| Operating Cash Flow | -427 | -218 | -221 | -133 | -130 |
| Free Cash Flow | -427 | -218 | -221 | -133 | -130 |